Key facts
- It has raised $390K; the latest was Early Stage VC in Mar 2026.
- Notable investors include Tech Incubator Program for Startup, Nvidia, KB Innovation HUB, Impact Foundation, Digital Healthcare Partners — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Risorius
- ·The full record, as it builds
Funding rounds
No funding rounds for Risorius are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Risorius
Developer of a drug response prediction system designed to forecast psychiatric drug effectiveness through individual data analysis. The company offers biometric data analysis using brain waves and heart rate variability, enabling the healthcare industry to quantify cognitive function and emotional state for objective mental health assessment.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2023
- Employees
- 13
- Website
- risorius.kr/
- Ownership
- Privately Held (backing)
Risorius doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Risorius shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Risorius in its N-PORT filings yet. We sweep new filings monthly.